|
| Code | Medication groups | Code | Medication subgroup |
|
| N05 | Psycholeptics - A group of drugs that tranquillises (central nervous system depressants) |
|
| N05A | Antipsychotics - drugs used to treat symptoms of psychosis (a severe mental disorder characterised by loss of contact with reality, delusions and hallucinations), common in conditions such as schizophrenia, mania and delusional disorder | N05AA | Phenothiazines with aliphatic side-chain |
 | N05AB | Phenothiazines with piperazine structure |
| N05AC | Phenothiazines with piperidine structure |
| N05AD | Butyrophenone derivatives |
| N05AE | Indole derivatives |
| N05AF | Thioxanthene derivatives |
| N05AH | Diazepines, oxazepines, thiazepines and oxepines |
| N05AL | Benzamides |
| N05AX | Other antipsychotics |
|
| N05B | Anxiolytics - drugs prescribed to treat symptoms of anxiety. | N05BA | Benzodiazepine derivatives |
|
| N05C | Hypnotics and sedatives - hypnotic drugs are used to induce sleep and treat severe insomnia. Sedative drugs are prescribed to reduce excitability or anxiety. | N05CD | Benzodiazepine derivatives |
|
| N06 | Psychoanaleptics - A group of drugs that stimulates the mood (central nervous system stimulants) |
|
| N06A | Antidepressants - drugs used to treat the symptoms of clinical depression. | N06AA | Non-selective monoamine reuptake inhibitors |
| N06AB | Selective serotonin reuptake inhibitors |
| N06AF | Monoamine oxidase inhibitors, non-selective |
| N06AG | Monoamine oxidase A inhibitors |
| N06AX | Other antidepressants |
|
| N06B | Psychostimulants, agents used for ADHD and nootropics - agents used for attention-deficit hyperactivity disorder and to improve impaired cognitive abilities (nootropics). | N06BA | Centrally acting sympathomimetics |
|
| Source: Australian Institute of Health and Welfare, 2014, 'Medicare-subsidised mental health-related prescriptions', viewed 13 August 2014, < https://mhsa.aihw.gov.au/services/medicare/> |
Print Page
Print All